Prevention of falls--a time to translate evidence into practice

98 5. Zijlmans JCM, Katzenschlager R, Daniel SE, Lees AJL The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004; 75: 545–7. 6. Thanvi B, Lo N, Robinson T. Vascular parkinsonism – an important cause of parkinsonism in older people. Age Ageing 2005; 34: 114–9. 7. Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson’s disease in a Scottish city. BMJ 1986; 292: 534–6. 8. Quinn N. Parkinsonism – recognition and differential diagnosis. BMJ 1995; 310: 447–52. 9. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001; 104: 63–7. 10. Zijlmans JCM, Daniel SE, Hughes AJ, Révész T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004; 19: 630–40. 11. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989; 4: 249–60. 12. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56: 98–102. 13. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004; 75: 1749–52. 14. Marshall V, Grossett D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003; 18: 1415–23. 15. Peralta C, Werner P, Holl B et al. Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J Neural Transm 2004; 111: 1473–83. Epub 2004 Aug 03. 16. Sibon I, Fenelon G, Quinn NP, Tison F. Vascular parkinsonism. J Neurol 2004; 251: 513–24.